FDA Inspection 669085 — AmerisourceBergen Drug Corporation

AmerisourceBergen Drug Corporation — FEI 3002533877

The FDA completed an inspection of AmerisourceBergen Drug Corporation on June 25, 2010 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 25, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Denver, CO (United States)